Connect with us

Health

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial – The Lancet

Consistent with international society recommendations, renin–angiotensin system inhibitorscan be safely continued in patients admitted to hospital with COVID-19….

Published

on

We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy   Terms and Conditions

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending